Skip To Content

 

Insights

Blogs

 

Sharing perspectives leads to greater understanding and fuels innovation

Check out our latest blog posts:

April 14, 2023 · Public Policy & Regulatory Affairs Team
Brief updates on policy developments across the country, including Oregon workers’ comp updated rules, and Virginia workers’ comp cancer presumption and anxiety disorder bills. Read more...
April 06, 2023 · Clinical Team
Our Brand–Generic Pipeline lists new medications approved by the U.S. FDA and first-time generics or brand alternatives that potentially may be prescribed for the treatment of a workers’ compensation or auto injury. The Brand–Generic Pipeline for Q1 2023 is now available -- read it here. Read more...
March 22, 2023 · Public Policy & Regulatory Affairs Team
Brief updates on Alabama workers’ compensation fee schedule, physician choice legislation in Montana and Iowa, and New York considering halting pharmacy direction of care. Read more...
March 01, 2023 · Public Policy & Regulatory Affairs Team
Brief updates on CA medical provider networks and utilization review, CO 10th annual stakeholder meetings, CT pharmacy treatment notifications, NY pharmacy direction of care, and policy developments in NJ and ND. Read more...
February 24, 2023 · Medicare Insights Team
On February 17, 2023, CMS announced a delay in the deadline for the final rule on Civil Money Penalties (CMP) from February 18, 2023 to February 18, 2024. Read more...
February 08, 2023 · Public Policy & Regulatory Affairs Team
Brief updates on several recent policy developments across the country. Read more...
January 19, 2023 · Public Policy & Regulatory Affairs Team
Brief updates on several recent policy developments across the country. Read more...
December 15, 2022 · Medicare Insights Team
The Centers for Medicare and Medicaid Services (CMS) held a webinar on December 6, 2022, regarding Section 111 Non-Group Health Plan best practices, compliance tips and common errors. Read more...
<< Previous      Next >>
Page 2 of 19